Items where authors include "Sebag-Montefiore, D"
Up a levelArticle
Bird, D orcid.org/0000-0001-6775-3603, Pearce, S, Teo, M et al. (8 more authors) (2022) Assessing the patient experience of anal and rectal cancer MR simulation for radiotherapy treatment planning. Journal of Radiotherapy in Practice, 21 (4). pp. 487-492. ISSN 1460-3969
Theophanous, S orcid.org/0000-0002-4148-3905, Lønne, P-I, Choudhury, A et al. (25 more authors) (2022) Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study. Diagnostic and Prognostic Research, 6 (1). 14. p. 14. ISSN 2397-7523
Theophanous, S, Samuel, R, Lilley, J et al. (4 more authors) (2022) Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review. BMC Cancer, 22 (1). 607. ISSN 1471-2407
Gilbert, A orcid.org/0000-0002-9142-1227, Homer, V, Brock, K et al. (18 more authors) (2022) Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision. The Lancet Healthy Longevity, 3 (12). e825-e838. ISSN 2666-7568
Love, SB, Cafferty, F, Snowdon, C et al. (33 more authors) (2022) Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units. Trials, 23 (1). p. 757. ISSN 1745-6215
Segelov, E, Guren, MG, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 et al. (6 more authors) (2022) “Global Multidisciplinary Team Meetings”: Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC). Clinical Colorectal Cancer, 21 (3). pp. 175-187. ISSN 1533-0028
Slevin, F orcid.org/0000-0002-7176-904X, Hanna, CR, Appelt, A orcid.org/0000-0003-2792-9218 et al. (4 more authors) (2022) The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal Cancer. Clinical Oncology, 34 (5). E210-E217. ISSN 0936-6555
Hudson, EM orcid.org/0000-0001-8758-7163, Noutch, S, Brown, S orcid.org/0000-0002-7975-7537 et al. (19 more authors) (2022) A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial. BMJ Open, 12 (4). e049119. ISSN 2044-6055
Osong, B, Masciocchi, C, Damiani, A et al. (18 more authors) (2022) Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery. Physics and Imaging in Radiation Oncology, 22. pp. 1-7. ISSN 2405-6316
Franco, P, Segelov, E, Johnsson, A et al. (11 more authors) (2022) A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer. Cancers, 14 (7). 1697. ISSN 2072-6694
Guren, MG, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259, Franco, P et al. (6 more authors) (2021) Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer. Clinical Colorectal Cancer, 20 (4). pp. 279-287. ISSN 1533-0028
Wakeham, K, Murray, L orcid.org/0000-0003-0658-6455, Muirhead, R et al. (10 more authors) (2021) Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy. Clinical Oncology, 33 (10). pp. 638-649. ISSN 0936-6555
Fokas, E, Appelt, A orcid.org/0000-0003-2792-9218, Glynne-Jones, R et al. (27 more authors) (2021) International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nature Reviews Clinical Oncology, 18. pp. 805-816. ISSN 1759-4774
Bird, D, Beasley, M, Nix, MG et al. (11 more authors) (2021) Patient position verification in magnetic-resonance imaging only radiotherapy of anal and rectal cancers. Physics and Imaging in Radiation Oncology, 19. pp. 72-77. ISSN 2405-6316
Hanna, CR, Slevin, F orcid.org/0000-0002-7176-904X, Appelt, A orcid.org/0000-0003-2792-9218 et al. (17 more authors) (2021) Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020. Clinical Oncology, 33 (4). pp. 214-223. ISSN 0936-6555
Flanagan, M, Clancy, C, Sorensen, J et al. (5 more authors) (2021) Neoadjuvant Short-Course Radiotherapy for Upper Third Rectal Tumors: Systematic Review and Individual Patient Data Metaanalysis of Randomized Controlled Trials. Annals of Surgical Oncology. ISSN 1068-9265
Wilkins, AC, Fontana, E, Nyamundanda, G et al. (19 more authors) (2021) Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer. Journal for ImmunoTherapy of Cancer, 9 (3). e001717. ISSN 2051-1426
Bird, D, Nix, MG, McCallum, H et al. (9 more authors) (2021) Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning. Radiotherapy and Oncology, 156. pp. 23-28. ISSN 0167-8140
Spencer, K orcid.org/0000-0002-6846-4341, Jones, C, Girdler, R et al. (10 more authors) (2021) The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study from the National Radiotherapy Dataset. The Lancet Oncology, 22 (3). pp. 309-320. ISSN 1470-2045
Bach, SP, Gilbert, A orcid.org/0000-0002-9142-1227, Brock, K et al. (21 more authors) (2021) Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. The Lancet Gastroenterology & Hepatology, 6 (2). pp. 92-105. ISSN 2468-1253
Bach, SP, Gilbert, A orcid.org/0000-0002-9142-1227, Brock, K et al. (20 more authors) (2021) Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. The Lancet Gastroenterology and Hepatology, 6 (2). pp. 92-105. ISSN 2468-1253
Holyoake, DLP, Robinson, M, Silva, M et al. (6 more authors) (2021) SPARC, a phase-I trial of pre‐operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer. Radiotherapy and Oncology, 155. pp. 278-284. ISSN 0167-8140
Spencer, K orcid.org/0000-0002-6846-4341, Jones, CM, Girdler, R et al. (10 more authors) (2021) The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study. Lancet Oncol.
Morris, EJA, Goldacre, R, Spata, E et al. (18 more authors) (2021) Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. The Lancet Gastroenterology & Hepatology. ISSN 2468-1253
Lewis, PJ, Morris, EJA orcid.org/0000-0002-1075-6544, Chan, CSK et al. (3 more authors) (2021) COVID RT – Assessing the Impact of COVID-19 on Radiotherapy in the UK. A National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Initiative in Partnership with the Royal College of Radiologists, the Society of Radiographers and the Institute of Physics and Engineering in Medicine. Clinical Oncology, 33 (1). e69-e72. ISSN 0936-6555
Sekhar, H, Kochhar, R, Carrington, B et al. (7 more authors) (2020) Three-dimensional (3D) magnetic resonance volume assessment and loco-regional failure in anal cancer: early evaluation case-control study. BMC Cancer, 20 (1). 1165. ISSN 1471-2407
O’Cathail, SM, Davis, S, Holmes, J et al. (8 more authors) (2020) A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR). Radiation Oncology, 15 (1). 151. ISSN 1748-717X
Glynne-Jones, R, Meadows, HM, Lopes, A et al. (3 more authors) (2020) Reply to the letter to the editor: DPD testing in radical chemoradiation for anal squamous cell carcinoma? by R. Muirhead, H. Jones, D. Gilbert, A. Gilbert & C. Jacobs. Annals of Oncology, 31 (11). pp. 1587-1588. ISSN 0923-7534
Brown, P, Appelt, A orcid.org/0000-0003-2792-9218, Sebag-Montefiore, D et al. (1 more author) (2020) In reply to letter to the editor: radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 47 (12). pp. 2735-2736. ISSN 1619-7070
Glynne-Jones, R, Meadows, HM, Lopes, A et al. (4 more authors) (2020) Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial. Annals of Oncology, 31 (10). pp. 1376-1385. ISSN 0923-7534
Thomson, DJ, Yom, SS, Saeed, H et al. (20 more authors) (2020) Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development. International Journal of Radiation: Oncology - Biology - Physics, 108 (2). pp. 379-389. ISSN 0360-3016
Rao, S, Sclafani, F, Eng, C et al. (18 more authors) (2020) International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct. Journal of Clinical Oncology, 38 (22). pp. 2510-2518. ISSN 0732-183X
Franks, KN, McParland, L, Webster, J et al. (21 more authors) (2020) SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resection. European Respiratory Journal. ISSN 0903-1936
O'Cathail, SM, Gilbert, DC, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 et al. (1 more author) (2020) Challenges and Consequences of COVID-19 in the Management of Anorectal Cancer: Coming Together Through Social Distancing. Clinical Oncology, 32 (7). pp. 413-416. ISSN 0936-6555
Marijnen, CAM, Peters, FP, Rödel, C et al. (12 more authors) (2020) International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiotherapy and Oncology, 148. pp. 213-215. ISSN 0167-8140
Fokas, E, Glynne-Jones, R, Appelt, A orcid.org/0000-0003-2792-9218 et al. (13 more authors) (2020) Outcome measures in multimodal rectal cancer trials. Lancet Oncology, 21 (5). e252-e264. ISSN 1470-2045
Gilbert, A, Drinkwater, K, McParland, L et al. (7 more authors) (2020) UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes. European Journal of Cancer, 128. pp. 7-16. ISSN 0959-8049
Peters, FP, Teo, MTW, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (7 more authors) (2020) Mesorectal radiotherapy for early stage rectal cancer: A novel target volume. Clinical and Translational Radiation Oncology, 21. pp. 104-111. ISSN 2405-6308
Shakir, R, Adams, R, Cooper, R et al. (10 more authors) (2020) Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 106 (2). pp. 329-339. ISSN 0360-3016
Levick, BA orcid.org/0000-0002-6371-8744, Gilbert, AJ, Spencer, KL orcid.org/0000-0002-6846-4341 et al. (5 more authors) (2020) Time to Surgery Following Short-Course Radiotherapy in Rectal Cancer and its Impact on Postoperative Outcomes. A Population-Based Study Across the English National Health Service, 2009–2014. Clinical Oncology, 32. e46-e52. ISSN 0936-6555
Chalmers, AJ, Chan, C, Sebag-Montefiore, D et al. (1 more author) (2020) CTRad 10 Years On: From 10-point Plan to Top 10 Achievements. Clinical Oncology, 32 (1). pp. 9-12. ISSN 0936-6555
Brown, PJ, Zhong, J, Frood, R orcid.org/0000-0003-2681-9922 et al. (5 more authors) (2019) Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT. European Journal of Nuclear Medicine and Molecular Imaging, 46 (13). pp. 2790-2799. ISSN 1619-7070
Bird, D, Henry, AM orcid.org/0000-0002-5379-6618, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 et al. (3 more authors) (2019) A Systematic Review of the Clinical Implementation of Pelvic Magnetic Resonance Imaging (MR)-Only Planning for External Beam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics, 105 (3). pp. 479-492. ISSN 0360-3016
Ofuya, M, McParland, L, Murray, L orcid.org/0000-0003-0658-6455 et al. (3 more authors) (2019) Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy. Clinical and Translational Radiation Oncology, 19. pp. 17-26. ISSN 2405-6308
Appelt, AL orcid.org/0000-0003-2792-9218, Kerkhof, EM, Nyvang, L et al. (8 more authors) (2019) Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study. Technical Innovations & Patient Support in Radiation Oncology, 11. pp. 14-21. ISSN 2405-6324
Brown, PJ, Hyland, R, Quyn, AJ et al. (5 more authors) (2019) Current concepts in imaging for local staging of advanced rectal cancer. Clinical Radiology, 74 (8). pp. 623-636. ISSN 0009-9260
Jones, CM, Spencer, K, Hitchen, C et al. (8 more authors) (2019) Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis. Clinical Oncology, 31 (6). pp. 356-364. ISSN 0936-6555
Downing, A orcid.org/0000-0002-0335-7801, Glaser, AW, Finan, PJ et al. (7 more authors) (2019) Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England. International Journal of Radiation Oncology*Biology*Physics, 103 (5). pp. 1132-1142. ISSN 0360-3016
Strauss, VY, Shaw, R, Virdee, PS et al. (13 more authors) (2019) Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine +/- nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2). BMC Cancer, 19. ARTN 121. ISSN 1471-2407
Renehan, AG, Muirhead, R, Berkman, L et al. (3 more authors) (2019) Early stage anal margin cancer: towards evidence-based management. Colorectal Disease. ISSN 1462-8910
Fish, R, Sanders, C, Adams, R et al. (8 more authors) (2018) A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. Lancet Gastroenterology and Hepatology, 3 (12). pp. 865-873. ISSN 2468-1253
Gollins, S, West, N orcid.org/0000-0002-0346-6709, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 et al. (11 more authors) (2018) A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer, 119 (6). pp. 697-706. ISSN 0007-0920
Jones, CM, Adams, R, Downing, A orcid.org/0000-0002-0335-7801 et al. (6 more authors) (2018) Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort. International Journal of Radiation Oncology*Biology*Physics, 101 (5). pp. 1202-1211. ISSN 0360-3016
Thompson, MK, Poortmans, P, Chalmers, AJ et al. (6 more authors) (2018) Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? British Journal of Cancer, 119. pp. 389-407. ISSN 0007-0920
Christophides, D, Appelt, AL orcid.org/0000-0003-2792-9218, Gusnanto, A et al. (2 more authors) (2018) Method for Automatic Selection of Parameters in Normal Tissue Complication Probability Modeling. International Journal of Radiation Oncology Biology Physics, 101 (3). pp. 704-712. ISSN 0360-3016
Renehan, AG, Muirhead, R and Sebag-Montefiore, D (2018) Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes. JAMA Surgery, 153 (7). p. 691. ISSN 2168-6254
Amos, R, Bulbeck, H, Burnet, NG et al. (9 more authors) (2018) Proton Beam Therapy – the Challenges of Delivering High-quality Evidence of Clinical Benefit. Clinical Oncology, 30. pp. 280-284. ISSN 0936-6555
Wale, A, Wexner, SD, Saur, NM et al. (6 more authors) (2018) Session 1: The evolution and development of the multidisciplinary team approach: USA, European and UK experiences – what can we do better? Colorectal Disease, 20 (S1). pp. 17-27. ISSN 1462-8910
Wyatt, J, Hedley, S, Johnstone, E et al. (7 more authors) (2018) Evaluating the repeatability and set-up sensitivity of a large field of view distortion phantom and software for magnetic resonance-only radiotherapy. Physics and Imaging in Radiation Oncology, 6. pp. 31-38. ISSN 2405-6316
Sodergren, SC, Johnson, CD, Gilbert, A et al. (13 more authors) (2018) Phase I–III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer. Radiotherapy and Oncology, 126 (2). pp. 222-228. ISSN 0167-8140
Teo, MTW, McParland, L, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (1 more author) (2018) Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review. International Journal of Radiation Oncology Biology Physics, 100 (1). pp. 146-158. ISSN 0360-3016
Johnstone, E, Wyatt, JJ, Henry, AM orcid.org/0000-0002-5379-6618 et al. (6 more authors) (2018) Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging–Only Radiation Therapy. International Journal of Radiation Oncology - Biology - Physics, 100 (1). pp. 199-217. ISSN 0360-3016
Rombouts, A, Al-Najami, I, Abbott, N et al. (22 more authors) (2017) Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ: British Medical Journal, 7 (12). ISSN 2044-6055
Harrington, K, Hall, E, Hawkins, M et al. (11 more authors) (2017) Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET). Clinical Oncology, 29 (11). pp. 707-710. ISSN 0936-6555
Murray, LJ orcid.org/0000-0003-0658-6455, Lilley, J, Hawkins, MA et al. (3 more authors) (2017) Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review. Radiotherapy and Oncology, 125 (2). pp. 213-222. ISSN 0167-8140
Gollins, S, West, N orcid.org/0000-0002-0346-6709, Sebag-Montefiore, D et al. (17 more authors) (2017) Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. British Journal of Cancer, 117. pp. 1286-1294. ISSN 0007-0920
Sekhar, H, Zwahlen, M, Trelle, S et al. (8 more authors) (2017) Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study. The Lancet Oncology, 18 (10). pp. 1348-1359. ISSN 1470-2045
Spencer, K orcid.org/0000-0002-6846-4341, Ellis, R, Birch, R orcid.org/0000-0003-1579-1397 et al. (6 more authors) (2017) Caution is required in the implementation of 90-day mortality indicators for radiotherapy in a curative setting: A retrospective population-based analysis of over 16,000 episodes. Radiotherapy and Oncology, 125 (1). pp. 140-146. ISSN 0167-8140
Fish, R, Sebag-Montefiore, D, Sanders, C et al. (2 more authors) (2017) Core outcome research measures in anal cancer. Colorectal Disease, 19 (8). pp. 782-783. ISSN 1462-8910
Glynne-Jones, R, Sebag-Montefiore, D, Meadows, HM et al. (9 more authors) (2017) Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial. The Lancet Oncology, 18 (3). pp. 347-356. ISSN 1470-2045
Muirhead, R, Drinkwater, K, O'Cathail, SM et al. (6 more authors) (2017) Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015. Clinical Oncology, 29 (3). pp. 188-197. ISSN 0936-6555
Mukherjee, S, Hurt, CN, Gwynne, S et al. (15 more authors) (2017) NEOSCOPE: A randomized phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer, 74. pp. 38-46. ISSN 0959-8049
Beets, G, Sebag-Montefiore, D, Andritsch, E et al. (22 more authors) (2017) ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review. Critical Reviews in Oncology/Hematology, 110. pp. 81-93. ISSN 1040-8428
Jones, CM, Goh, V, Sebag-Montefiore, D et al. (1 more author) (2017) Biomarkers in anal cancer: from biological understanding to stratified treatment. British Journal of Cancer, 116 (2). pp. 156-162. ISSN 0007-0920
Downing, A orcid.org/0000-0002-0335-7801, Morris, EJA orcid.org/0000-0002-1075-6544, Corrigan, N et al. (13 more authors) (2017) High hospital research participation and improved colorectal cancer survival outcomes: a population-based study. Gut, 66 (1). pp. 89-96. ISSN 0017-5749
Sharma, RA, Plummer, R, Stock, JK et al. (36 more authors) (2016) Clinical development of new drug-radiotherapy combinations. Nature Reviews Clinical Oncology, 13 (10). pp. 627-642. ISSN 1759-4774
Holyoake, DL, Robinson, M, Grose, D et al. (7 more authors) (2016) Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer. Radiotherapy and Oncology, 121 (1). pp. 86-91. ISSN 0167-8140
Ward, G, Ramasamy, S, Sykes, JR et al. (11 more authors) (2016) Superiority of Deformable Image Co-registration in the Integration of Diagnostic Positron Emission Tomography-Computed Tomography to the Radiotherapy Treatment Planning Pathway for Oesophageal Carcinoma. Clinical Oncology, 28 (10). pp. 655-662. ISSN 0936-6555
Holyoake, DL, Ward, E, Grose, D et al. (11 more authors) (2016) A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol. BMC Cancer, 16. 728. ISSN 1471-2407
Morris, EJA, Finan, PJ, Spencer, K et al. (7 more authors) (2016) Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service. Clinical Oncology, 28 (8). pp. 522-531. ISSN 0936-6555
Appelt, AL orcid.org/0000-0003-2792-9218 and Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 (2016) Technological advances in radiotherapy of rectal cancer: opportunities and challenges. Current Opinion in Oncology, 28 (4). pp. 353-358. ISSN 1040-8746
Snee, MP, McParland, L, Collinson, F et al. (10 more authors) (2016) The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot and Feasibility Studies, 2 (1). 5.
Gollins, S and Sebag-Montefiore, D (2016) Neoadjuvant treatment strategies for locally advanced rectal cancer. Clinical Oncology, 28 (2). 146 - 151. ISSN 0936-6555
Downing, A, Morris, EJ, Aravani, A et al. (4 more authors) (2015) The Effect of the UK Coordinating Centre for Cancer Research Anal Cancer Trial (ACT1) on Population-based Treatment and Survival for Squamous Cell Cancer of the Anus. Clinical Oncology, 27 (12). 708 - 712. ISSN 0936-6555
Sodergren, SC, Vassiliou, V, Dennis, K et al. (7 more authors) (2015) Systematic Review of the Quality of Life issues associated with Anal Cancer and its treatment with Radiochemotherapy. Supportive Care in Cancer, 23 (12). 3613 - 3623. ISSN 0941-4355
Teo, MTW, Sebag-Montefiore, D and Donnellan, CF (2015) Prevention and Management of Radiation-induced Late Gastrointestinal Toxicity. Clinical Oncology, 27 (11). 656 - 667. ISSN 0936-6555
Wright, P orcid.org/0000-0001-6129-4143, Downing, A orcid.org/0000-0002-0335-7801, Morris, EJA orcid.org/0000-0002-1075-6544 et al. (5 more authors) (2015) Identifying Social Distress: A Cross-Sectional Survey of Social Outcomes 12 to 36 Months After Colorectal Cancer Diagnosis. Journal of Clinical Oncology, 33 (30). pp. 3423-3430. ISSN 0732-183X
Gilbert, AJ, Ziegler, L, Martland, M et al. (4 more authors) (2015) Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting. International Journal of Radiation Oncology - Biology - Physics, 92 (3). 555 - 567. ISSN 0360-3016
Morris, E, Finan, P, Thomas, J et al. (4 more authors) (2015) Using the National Radiotherapy Dataset within the National Cancer Data Repository to investigate patterns of use of radiotherapy in the management of surgically treated rectal cancer across the English NHS. European Journal of Cancer Care, 24 (S1). pp. 20-21. ISSN 0961-5423
Spencer, KL, Morris, E, Dugdale, E et al. (5 more authors) (2015) 30 day mortality in adult palliative radiotherapy - A retrospective population based study of 14,972 treatment episodes. Radiotherapy and Oncology, 115 (2). 264 - 271. ISSN 0167-8140
Gilbert, A, Sebag-Montefiore, D, Davidson, S et al. (1 more author) (2015) Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. Gynecologic Oncology, 136 (3). pp. 429-439. ISSN 0090-8258
Downing, A orcid.org/0000-0002-0335-7801, Morris, EJA orcid.org/0000-0002-1075-6544, Richards, M et al. (12 more authors) (2015) Health-related quality of life after colorectal cancer in England: A patient-reported outcomes study of individuals 12 to 36 months after diagnosis. Journal of Clinical Oncology, 33 (6). pp. 616-624. ISSN 0732-183X
Mukherjee, S, Hurt, CN, Gwynne, S et al. (16 more authors) (2015) NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer, 15 (1). ARTN 48. ISSN 1471-2407
Murray, LJ orcid.org/0000-0003-0658-6455, Thompson, CM, Lilley, J et al. (4 more authors) (2015) Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy. Physics in Medicine and Biology, 60 (3). pp. 1237-1257. ISSN 0031-9155
Wilkinson, JR, Morris, EJ, Downing, A et al. (4 more authors) (2014) The rising incidence of anal cancer in England 1990-2010: a population-based study. Colorectal Disease, 16 (7). O234 - O239. ISSN 1462-8910
Murray, LJ orcid.org/0000-0003-0658-6455, Cosgrove, V, Lilley, J et al. (5 more authors) (2014) Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT). Radiotherapy and Oncology, 110 (2). pp. 298-302. ISSN 0167-8140
Craven, I, Crellin, A, Cooper, R et al. (3 more authors) (2007) Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. British Journal of Cancer, 97 (10). pp. 1333-1337. ISSN 0007-0920
Melcher, AA and Sebag-Montefiore, D (2003) Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost. British Journal of Cancer, 88 (9). pp. 1352-1357. ISSN 0007-0920
Conference or Workshop Item
Bird, D, Nix, M, Tyyger, M et al. (11 more authors) (2021) Evidence supporting anal and rectal cancer MR-only radiotherapy planning clinical implementation. In: ESTRO 2021, 28-31 Aug 2021, Madrid, Spain & Online.
Proceedings Paper
Bach, SP, De Wilt, JHW, Peters, F et al. (18 more authors) (2022) STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer? In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting I, 02-07 Jun 2022, Chicago, IL, USA. American Society of Clinical Oncology .
Shakir, R, Adams, R, Cooper, R et al. (10 more authors) (2019) P-159: Patterns and predictors of relapse following radical chemoradiotherapy delivered using intensity-modulated radiotherapy with a simultaneous integrated boost in anal squamous cell carcinoma. In: Annals of Oncology. ESMO 21st World Congress on Gastrointestinal Cancer 2019, 03-06 Jul 2019, Barcelona, Spain. Oxford University Press .
Johnstone, E, Wyatt, J, Henry, A orcid.org/0000-0002-5379-6618 et al. (8 more authors) (2018) EP-2136: Assessing the stability of MRI geometric distortions on multiple scanners. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S1177-S1177.
Brown, S, Van Herk, M, Chuter, R et al. (18 more authors) (2018) Advanced Radiotherapy Technologies Network in the UK (ART-NET) - focus on lung cancer. In: Lung Cancer. 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin, Ireland. Elsevier , S60-S60.
Robinson, M, Christophides, D, Abbott, N et al. (7 more authors) (2017) A Novel Pretrial Contouring Exercise for the UK led PersonaLising Anal cancer radioTherapy dOse (PLATO) Trial. In: Proceedings of the American Society for Radiation Oncology. ASTRO's 59th Annual Meeting, 24-27 Sep 2017, San Diego Convention Center, San Diego California. Elsevier , E181-E182.
Wyatt, J, Hedley, S, Johnstone, E et al. (7 more authors) (2017) EP-1708: Investigating the reproducibility of geometric distortion measurements for MR-only radiotherapy. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S935-S936.
Appelt, AL orcid.org/0000-0003-2792-9218, Teo, M, Christophides, D et al. (5 more authors) (2017) EP-1748: Mesorectal-only irradiation for early stage rectal cancer: Target volumes and dose to organs at risk. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S962-S963.
Christophides, D, Gilbert, A, Appelt, AL orcid.org/0000-0003-2792-9218 et al. (3 more authors) (2017) OC-0255: Practical use of principal component analysis in radiotherapy planning. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S129-S130.
Christophides, D, Appelt, AL orcid.org/0000-0003-2792-9218, Lilley, J et al. (1 more author) (2017) PO-0853: A method for automatic selection of parameters in NTCP modelling. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S463-S464.
Gilbert, A, Davidson, S, Velikova, G orcid.org/0000-0003-1899-5942 et al. (1 more author) (2017) SP-0519: Collecting PROs in clinical practice to assess radiotherapy toxicity and develop normal tissue complication probability models. In: Radiotherapy and Oncology. ESTRO 36, 05-09 May 2017, Vienna, Austria. Elsevier , S275-S275.
Bestall, JC orcid.org/0000-0001-6765-6379, Franks, KN, Collinson, F et al. (7 more authors) (2017) Exploring Recruitment Factors in a Feasibility Trial of SABR versus Surgery. In: Journal of Thoracic Oncology. IASLC 17th World Conference on Lung Cancer (IASLC WCLC 2016), 03-07 Dec 2016, Vienna. Elsevier , S1093-S1093.
Sebag-Montefiore, D, Adams, R, Bell, S et al. (17 more authors) (2016) The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus. In: Proceedings of the American Society for Radiation Oncology. 58th Annual Meeting of the American Society for Radiation Oncology, 25-28 Sep 2016. Elsevier , E164-E165.
Taylor, M, Wood, H, Tinkler-Hundal, E et al. (9 more authors) (2015) Investigating the Challenges of Using Historical Formalin-Fixed Paraffin-Embedded (FFPE) Material from the MRC CR07 Rectal Cancer Trial Using the Affymetrix OncoScan (R) FFPE Assay and Next Generation Sequencing. In: Journal of Pathology. Dublin Pathology 2015: 8th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 23-25 Jun 2015, Dublin, Ireland. Wiley , S38-S38.
Morris, EJA, Finan, PJ, Quirke, P et al. (5 more authors) (2015) Wide variation in the use of radiotherapy in the management of surgically treated rectal cancer across the english NHS. In: Gut. 2nd Digestive Disorders Federation Conference, 22-25 Jun 2015, London, UK. BMJ Publishing Group , A148-A148.
Gollins, S, Sebag-Montefiore, D, Adams, R et al. (9 more authors) (2015) A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). In: Journal of Clinical Oncology. 2015 ASCO Annual Meeting, 29 May - 02 Jun 2015, Chicago, IL, USA. American Society of Clinical Oncology .
Gilbert, AJ, O'Connell Francischetto, E, Blazeby, J et al. (4 more authors) (2015) Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach. In: The Lancet. Academy of Medical Sciences: Spring Meeting for Clinician Scientisits in Training, 25 Feb 2015, Royal College of Physicians, London. Elsevier , 38 - 38.